Sana Biotechnology
SANA
2.70
-0.02
-0.74%
Sana Biotechnology
US · SANA
#3404 by market cap
Listed 2021
2.70
-0.02
-0.74%
Live - 5344 symbols - heartbeat 269s ago
· 2026-10-08 09:59
Pre-market
2.72
0.00%
After-hours
2.80
+2.94%
Overnight
2.77
+1.84%
- Market cap
- 808.27M
- P/E (TTM)i
- -3.60
- P/Bi
- 5.23
- EPSi
- -0.96
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on SANA?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | 21.78M | 28.27M | 50.41M | 71.56M | 73.30M | 64.04M | 44.30M |
| Research & development | -- | 119.38M | 257.88M | 306.50M | 201.00M | 212.83M | 206.79M | 161.41M |
| Operating profit | -- | -141.15M | -286.15M | -356.91M | -272.56M | -286.13M | -270.83M | -205.71M |
| Pretax profit | -- | -138.33M | -285.31M | -355.93M | -269.48M | -283.26M | -266.76M | -244.17M |
| Tax | -- | -7.55M | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -130.78M | -285.31M | -355.93M | -269.48M | -283.26M | -266.76M | -244.17M |
| Basic EPS | -- | -1 | -2 | -2 | -1 | -1 | -1 | -1 |
| Diluted EPS | -- | -1.00 | -1.63 | -2.14 | -1.43 | -1.46 | -1.16 | -0.96 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 11.48M | 10.34M | 10.29M | 12.19M | 11.46M | 10.78M |
| Research & development | 39.15M | 40.02M | 33.23M | 49.01M | 37.15M | 54.64M |
| Operating profit | -50.63M | -50.36M | -43.52M | -61.20M | -48.61M | -65.42M |
| Pretax profit | -49.39M | -93.80M | -42.15M | -58.83M | -47.21M | -63.64M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -49.39M | -93.80M | -42.15M | -58.83M | -47.21M | -63.64M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.21 | -0.39 | -0.16 | -0.21 | -0.17 | -0.22 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 32.60M | 144.26M | 384.47M | 558.10M | 444.44M | 213.52M | 160.81M | 148.68M |
| Cash & ST investments | 30.63M | 138.98M | 378.26M | 551.00M | 423.96M | 205.20M | 152.50M | 138.38M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 34.33M | 415.19M | 730.30M | 1.13B | 822.72M | 565.30M | 501.02M | 416.89M |
| Total current liabilities | 1.79M | 19.32M | 31.45M | 99.24M | 111.50M | 64.49M | 45.43M | 78.73M |
| Short-term debt | -- | 1.34M | 3.71M | 9.16M | 12.39M | 13.20M | 12.53M | 14.94M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 47,521,000.00 | 557,734,000.00 | 1,151,480,000.00 | 400,905,000.00 | 323,405,000.00 | 277,793,000.00 | 250,516,000.00 | 256,006,000.00 |
| Total equity | -13.19M | -142.54M | -421.18M | 728.50M | 499.32M | 287.51M | 250.50M | 160.88M |
| Retained earnings | -13.25M | -144.13M | -429.43M | -785.36M | -1.05B | -1.34B | -1.60B | -1.85B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 112.73M | 82.50M | 161.76M | 148.68M | 111.69M | 170.63M |
| Cash & ST investments | 104.70M | 72.67M | 153.05M | 138.38M | 101.14M | 160.49M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 445.47M | 361.65M | 435.43M | 416.89M | 373.59M | 431.52M |
| Total current liabilities | 33.16M | 33.44M | 35.51M | 78.73M | 86.27M | 123.75M |
| Short-term debt | 13.00M | 13.83M | 14.37M | 14.94M | 14.88M | 14.51M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 236,391,000.00 | 239,089,000.00 | 240,124,000.00 | 256,006,000.00 | 254,353,000.00 | 276,954,000.00 |
| Total equity | 209.08M | 122.56M | 195.31M | 160.88M | 119.24M | 154.57M |
| Retained earnings | -1.65B | -1.75B | -1.79B | -1.85B | -1.90B | -1.96B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -- | -85.52M | -137.98M | -251.05M | -290.05M | -253.58M | -223.15M | -143.83M |
| Depreciation & amortization | -- | 1.83M | 5.92M | 11.07M | 15.63M | 17.54M | 15.50M | 12.75M |
| Free cash flow | -- | -111.64M | -161.85M | -280.92M | -310.93M | -273.61M | -256.58M | -144.77M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 0 | 631.75M | 601.00K | -- | -- | -- |
| Ending cash balance | -- | 81.81M | 126.95M | 261.85M | 187.27M | 137.35M | 131.40M | 76.07M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -48.66M | -33.10M | -29.43M | -32.64M | -37.38M | -32.79M |
| Depreciation & amortization | 3.65M | 2.86M | 3.19M | 3.05M | 2.39M | 2.23M |
| Free cash flow | -48.79M | -32.99M | -29.47M | -33.51M | -37.67M | -34.41M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 109.47M | -- | -- | -- |
| Ending cash balance | 100.33M | 75.47M | 107.55M | 76.07M | 88.00M | 61.27M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -231.64 | -43.90 | -72.00 | -99.17 | -118.70 |
| ROA %i | -- | -58.12 | -49.79 | -38.28 | -27.61 | -40.81 | -50.03 | -53.20 |
| ROIC %i | -- | -- | -- | -145.50 | -37.77 | -58.69 | -75.30 | -84.87 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -113.08 |
| EBIT margin %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 18.26 | 7.47 | 12.22 | 5.62 | 3.99 | 3.31 | 3.54 | 1.89 |
| Quick ratioi | 17.16 | 7.19 | 12.03 | 5.55 | 3.80 | 3.18 | 3.36 | 1.76 |
| Debt / assetsi | 0.00 | 11.49 | 9.85 | 9.82 | 13.16 | 18.41 | 18.80 | 18.92 |
| LT debt / equityi | -- | -- | -- | 13.97 | 19.20 | 31.62 | 32.60 | 39.73 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -71.44 | -109.12 | -96.11 | -118.70 | -147.41 | -152.87 |
| ROA %i | -37.04 | -51.45 | -47.13 | -53.20 | -59.09 | -53.41 |
| ROIC %i | -55.55 | -79.84 | -71.65 | -84.87 | -99.32 | -99.08 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 3.40 | 2.47 | 4.55 | 1.89 | 1.29 | 1.38 |
| Quick ratioi | 3.16 | 2.17 | 4.31 | 1.76 | 1.17 | 1.30 |
| Debt / assetsi | 20.50 | 23.64 | 18.89 | 18.92 | 20.16 | 17.09 |
| LT debt / equityi | 37.46 | 58.47 | 34.75 | 39.73 | 50.70 | 38.32 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Quote time 2026-10-08 09:59:55 · For reference only, not investment advice and not tailored to your situation.